Lawmakers Question, Chide FDA Leaders at Congressional Hearing

Drug shortages, patent tussles, and gripes about the Inflation Reduction Act (IRA) headlined the conversation at an FDA “check-up” meeting conducted by the House Energy and Commerce’s subcommittee on health.
Source: Drug Industry Daily